Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01) (NCT06941272)Merck Sharp & Dohme LLC2025-05-26
Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury (NCT06847555)Shandong Cancer Hospital and Institute2025-05-25
Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer (NCT07267078)Peking Union Medical College Hospital2025-05-25
Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients (NCT07137793)Tanta University2025-05-25
Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies (NCT06993025)Tianjin Medical University Cancer Institute and Hospital2025-05-25
A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Orthopedic Surgery (NCT06901830)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2025-05-23
XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation (NCT06936527)NovaOnco Therapeutics Co., Ltd.2025-05-23
Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617 (NCT06972628)Ebrahim S Delpassand2025-05-23
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors (NCT06801041)M.D. Anderson Cancer Center2025-05-23
Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1) (NCT06907342)St. Olavs Hospital2025-05-23
Oral Ketorolac for IUD Pain Reduction (NCT06853327)University of North Carolina, Chapel Hill2025-05-23
Boron Neutron Capture Therapy With B10 L-BPA for Unresectable Recurrent Head and Neck Cancers (NCT06952868)China Medical University Hospital2025-05-23
A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes (NCT06901349)Eli Lilly and Company2025-05-23
Lacripep for Corneal Wound Healing Study (NCT06854393)Henry M. Jackson Foundation for the Advancement of Military Medicine2025-05-23
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer (NCT06903377)Suzhou Zelgen Biopharmaceuticals Co.,Ltd2025-05-23
Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC (NCT06999694)Chang Gung Memorial Hospital2025-05-22
A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI) (NCT06794541)Tetraphase Pharmaceuticals, Inc2025-05-22
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial) (NCT06616584)SWOG Cancer Research Network2025-05-22
124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome (NCT06907849)University of Tennessee Graduate School of Medicine2025-05-22
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. (NCT06697301)Eikon Therapeutics2025-05-22
Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate Depression (NCT06751784)University of Basel2025-05-22
Glycemic Regulation as Endometriosis Adjunct Treatment (NCT06611501)Boston Children's Hospital2025-05-22
The Efficacy and Safety of IBI351, Cetuximab β Combined With FOLFIRI as First-line /IBI351, Cetuximab β as Second-line in the Treatment of KRAS G12C-mutated Metastatic Colorectal Cancer (NCT06959589)Second Affiliated Hospital, Zhejiang University, School of Medicine2025-05-22
Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC (NCT06999707)Chang Gung Memorial Hospital2025-05-22
Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial (NCT06992128)Institute of Hematology & Blood Diseases Hospital, China2025-05-22
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria (NCT06865651)Novartis Pharmaceuticals2025-05-22
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer (NCT07023484)The University of Hong Kong2025-05-22
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression (NCT06682793)A2 Biotherapeutics Inc.2025-05-22
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia (NCT06843590)Alkermes, Inc.2025-05-22
A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis (NCT07035041)InventisBio Co., Ltd2025-05-22
A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer (NCT06974929)Jiangsu HengRui Medicine Co., Ltd.2025-05-22
A Study for HSK44459 in Participants With Atopic Dermatitis (NCT06996912)Xizang Haisco Pharmaceutical Co., Ltd2025-05-22
5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer (NCT06961955)University of Utah2025-05-21
ZR-MTX for PIOL Phase II Trial (NCT06973811)Peking Union Medical College Hospital2025-05-21
Teclistamab in Previously Treated AL Amyloidosis (NCT06935162)Peking Union Medical College Hospital2025-05-21
An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint (NCT06485843)Ageless Biotech, Inc.2025-05-21
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia (NCT06847269)St. Jude Children's Research Hospital2025-05-21
AK129 Combination Therapy for Advanced Solid Tumors (NCT06943820)Akeso2025-05-21
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant (NCT07006506)Memorial Sloan Kettering Cancer Center2025-05-21
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR) (NCT06966479)Upstream Bio Inc.2025-05-21
Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT (NCT06984536)Peking University People's Hospital2025-05-21
This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer (NCT06978153)Tang-Du Hospital2025-05-20
Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia (NCT06971913)Peking University People's Hospital2025-05-20
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors (NCT06938880)Suzhou Zelgen Biopharmaceuticals Co.,Ltd2025-05-20
Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment (NCT06988527)Dar Al Uloom University2025-05-20
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery (NCT06780787)City of Hope Medical Center2025-05-20
Effects of Carnosine In Patients With Peripheral Arterial Disease Patients (NCT06480760)Shahid Baba2025-05-20
Comparison of Inter-appointment Pain Reduction During Root Canal Treatment in Symptomatic Apical Periodontitis by Using Intracanal Medicaments; Chlorhexidine Gel and Single Antibiotic Paste Nitrofurantoin (NCT07198919)Altamash Institute of Dental Medicine2025-05-20
Perioperative Treatment of Hepatoid Adenocarcinoma of Stomach (NCT06992362)Peking University Cancer Hospital & Institute2025-05-20
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol (NCT07012993)Akiva Mintz2025-05-20
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma (NCT06977581)Pfizer2025-05-20
A Trial With EMP16 in Preparation for Late Phase Studies (NCT06993428)Empros Pharma AB2025-05-20
JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC (NCT06944470)Shanghai Junshi Bioscience Co., Ltd.2025-05-20
Early Norepinephrine in Trauma Patients With Hemorrhagic Shock (NCT06977659)Visarat Palitnonkiat2025-05-20
This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight (NCT07017179)AstraZeneca2025-05-20
A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON) (NCT06962852)Boehringer Ingelheim2025-05-20
A Study of Cetuximabβ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer (NCT07000305)Tao Zhang2025-05-20
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS (NCT06680752)ARCE Therapeutics, Inc.2025-05-20
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA) (NCT06868628)Tiziana Life Sciences LTD2025-05-19
VR-based Physical Activity and Reminiscence Therapy (NCT06934720)Hong Kong University of Science and Technology2025-05-19
Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients (NCT06991712)Christopher Kai Shun Leung2025-05-19
DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease (NCT06918808)Direct Biologics, LLC2025-05-19
Folinic Acid as a Treatment for Autism Spectrum Disorder in Children (NCT07630506)KK Women's and Children's Hospital2025-05-19
Escitalopram in Asthma Patients With Frequent Exacerbation (NCT06216535)University of Texas Southwestern Medical Center2025-05-19
Personalized Antisense Oligonucleotide Therapy for A Single Participant With ASXL3 Gene Mutation (NCT07197268)n-Lorem Foundation2025-05-19
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels (NCT06934200)Johns Hopkins University2025-05-19
TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial (NCT06987123)Sun Yat-sen University2025-05-18
Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy (NCT06985485)The First Affiliated Hospital of Soochow University2025-05-17
Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ (NCT06985602)Jiangsu Cancer Institute & Hospital2025-05-16
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial) (NCT06672146)National Cancer Institute (NCI)2025-05-16
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma (NCT06883526)Suzhou Zelgen Biopharmaceuticals Co.,Ltd2025-05-16
Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder (NCT06969170)Claudio N Soares2025-05-16
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense (NCT06993610)Zura Bio Inc2025-05-16
A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma (NCT07063888)Cancer Institute and Hospital, Chinese Academy of Medical Sciences2025-05-16
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-1) (NCT06930612)Beijing Keymed Biosciences Co., Ltd.2025-05-16
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis (NCT06947993)Novartis Pharmaceuticals2025-05-16
High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD (NCT06954025)ARQ National Psychotrauma Centre2025-05-16
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial (NCT05820126)Ottawa Hospital Research Institute2025-05-16
Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL (NCT06849713)Massachusetts General Hospital2025-05-16
Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer (NCT06851442)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2025-05-16
A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis (NCT06981091)S-INFINITY Pharmaceuticals Co., Ltd2025-05-16
Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation. (NCT07162688)Fujian Medical University2025-05-16
Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls (NCT06676774)University Hospital, Basel, Switzerland2025-05-16
CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation (NCT06762964)Mayo Clinic2025-05-16
TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma (NCT06912711)Sun Yat-sen University2025-05-16
Evaluation of Locally Applied Ferulic Acid as Adjunct to Mechanical Debridement in Treatment of Periodontitis (NCT07404072)Salah Awad Alanazi2025-05-16
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment (NCT07010692)Bruce Robinson, MD2025-05-16
Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients (NCT06824454)Stanford University2025-05-15
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer(Neo-Color) (NCT06949111)Hebei Medical University Fourth Hospital2025-05-15
Tarlatamab for Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma (TAURUS) (NCT06816394)National Taiwan University Hospital2025-05-15
Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression (NCT06967857)Prof. Dr. Frank Behrens2025-05-15
High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis (NCT06971406)Qiming Wang2025-05-15
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects (NCT06953063)Chendu DIAO Pharmaceutical Group CO., LTD.2025-05-15
Transcutaneous Vagus Nerve Stimulation in SLE (NCT06987565)Northwell Health2025-05-15
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight (NCT06987513)Altimmune, Inc.2025-05-15
Zemaira Eosinophilic Esophagitis Pilot Study (NCT05485155)Children's Hospital Medical Center, Cincinnati2025-05-15
Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma (NCT06927128)Changhai Hospital2025-05-15
Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination. (NCT07489989)Daihong Liu2025-05-15
Safety and Efficacy of Pucotenlimab in pLECC (NCT06969534)Sun Yat-sen University2025-05-15
A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia (NCT07028073)The First Affiliated Hospital of Soochow University2025-05-15
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.